[1]李 静,杨 洋,肖 涛,等.稳定表达hOAT1的HEK293细胞系的建立及鉴定[J].中国药理学通报,2018,(10):1471-1476.[doi:10.3969/j.issn.1001-1978.2018.10.028]
 LI Jing,YANG Yang,XIAO Tao,et al.Establishment and identification of HEK293 cell lines with stable expression of hOAT1[J].Chinese Pharmacological Bulletin,2018,(10):1471-1476.[doi:10.3969/j.issn.1001-1978.2018.10.028]
点击复制

稳定表达hOAT1的HEK293细胞系的建立及鉴定()
分享到:

《中国药理学通报》[ISSN:/CN:]

卷:
期数:
2018年10期
页码:
1471-1476
栏目:
实验方法学
出版日期:
2018-10-26

文章信息/Info

Title:
Establishment and identification of HEK293 cell lines with stable expression of hOAT1
文章编号:
1001-1978(2018)10-1471-06
作者:
李 静123杨 洋23肖 涛23李 韬23欧 瑜4傅晓钟23刘 亭1
贵州医科大学 1.贵州省药物制剂重点实验室/药用植物功效与利用国家重点实验室、2.药学院、3.民族药与中药开发应用教育部工程研究中心,贵州 贵阳 550004; 4.贵阳市妇幼保健院药剂科,贵州 贵阳 550002
Author(s):
LI Jing123 YANG Yang23 XIAO Tao23 LI Tao23 OU Yu4 FU Xiao-zhong23 LIU Ting1
1.Guizhou Provincial Key Lab of Pharmaceutics / State Key Lab of Functions and Applications of Medicinal Plant; 2.School of Pharmacy; 3.Engineering Research Center for the Development and Application of Ethnic Medicine and TCM(Ministry of Education), Guizhou Medical University, Guiyang 550004, China; 4.Pharmacy Dept,Maternal and Child Health Hospital of Guiyang Province, Guiyang 550002, China
关键词:
人有机阴离子转运体1 融合蛋白 稳定转染 HEK293细胞 对氨基马尿酸 丙磺舒
Keywords:
hOAT1 fusion protein stable transfection HEK293 cells p-aminohippuric acid(PAH) probenecid
分类号:
R322.61; R329.2; R329.24; R341; R394.2; R978.7; R977.6
DOI:
10.3969/j.issn.1001-1978.2018.10.028
文献标志码:
A
摘要:
目的 构建人肾脏近曲小管阴离子转运体1(human organic anion transporter 1,hOAT1)-增强型绿色荧光蛋白(EGFP)质粒,获得稳定表达pEGFP-hOAT1的HEK-293细胞系。方法 构建EGFP与hOAT1的融合基因表达载体pEGFP-hOAT1,并利用FuGENE 6转染试剂将其转染至HEK293细胞中,用荧光显微镜观察绿色荧光蛋白表达情况,经G418抗性筛选获得稳定转染细胞株。用RT-PCR法、qRT-PCR法和Western blot技术,检测稳定转染细胞及正常细胞hOAT1 mRNA和蛋白的表达情况,并进一步用超高效液相色谱-串联质谱法(UPLC-MS/MS)考察稳定转染细胞的对氨基马尿酸摄取能力,以及丙磺舒对hOAT1的抑制作用。结果 使用该文的方法,细胞转染率可达90%。RT-PCR、qRT-PCR、Western blot,以及对氨基马尿酸摄取、丙磺舒抑制实验结果显示,相对于正常组,转染细胞在荧光显微镜下呈绿色荧光,其hOAT1表达均呈阳性(P<0.01); 稳定转染细胞的对氨基马尿酸摄取能力明显升高(P<0.05),且丙磺舒对hOAT1有明显的抑制作用(P<0.05)。结论 高效快速地建立了稳定高表达hOAT1的HEK293细胞系,为核苷类膦酸类似物这类药物引起的临床剂量依赖性肾毒性的机制研究奠定了模型基础,也为体外研究hOAT1底物或抑制剂的筛选提供了一个便利的工具。
Abstract:
Aim To construct the human organic anion transporter 1(hOAT1)-enhanced green fluorescent protein(EGFP)plasmid and obtain HEK-293 cell line stably expressing pEGFP-hOAT1.Methods The recombinant plasmid pEGFP-hOAT1 expressing EGFP-hOAT1 fusion protein was constructed, and the recombinant plasmid was transfected into HEK293 cells using FuGENE 6 transfection reagent.Fluorescent microscope was used to observe the expression of green fluorescent protein(GFP).The monoclonal cell lines were selected by G418 resistance screening and expanded to obtain stable transfected cell lines.The expression of hOAT1 mRNA and protein in stable transfected cells and normal cells was detected by RT-PCR, qRT-PCR and Western blot, and p-aminohippuric acid uptake capacity, and probenecid hOAT1 inhibitory effect in stable transfected HEK293 cells were further investigated using UPLC-MS/MS technique.Results Using this method, the cell transfection rate could reach 90%.The results of RT-PCR, qRT-PCR, Western blot and p-aminohippuric acid uptake and probenecid inhibition showed that the hOAT1 expression was positive in the transfected cells under the fluorescence microscope as compared with normal group(P<0.01), the uptake of p-aminohippuric acid in transfected cells significantly increased(P<0.05), and hOAT1 was markedly inhibited by probenecid(P<0.05).Conclusions HEK293 cell line with stable and high expression of hOAT1 has been established efficiently and rapidly, which lays the foundation for the study of the mechanism of clinical dose-dependent nephrotoxicity induced by antiviral nucleoside or nucleotide analogues and also provides a convenient tool for in vitro screening hOAT1 substrates or inhibitors.

参考文献/References:

[1] Sekine T, Watanabe N, Hosoyamada M, et al.Expression cloning and characterization of a novel multispecific organic anion transporter[J].J Biol Chem, 1997,272(30): 18526-9.
[2] Burckhardt G, Wolff N A.Structure of renal organic anion and cation transporters[J].Am J Physiol, 2000, 278(6): 853-66.
[3] Ho E S, Lin D C, Mendel D B, et al.Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1[J].J Am Soc Nephrol, 2000,11(3):383-93.
[4] Qaqish R B, Mattes K A, Ritchie D J.Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection[J].Clin Ther, 2003,25(12):3084-99.
[5] 罗 敏,傅晓钟,肖 涛,等.人寡肽转运体1转染MDCK 细胞与转染HeLa 细胞的比较研究[J].中国药理学通报, 2017,33(2):280-4.
[5] Luo M, Fu X Z, Xiao T, et al.Comparison of hPepT1 transfected MDCK cells to hPepT1 transfected HeLa cells[J].Chin Pharmacol Bull, 2017,33(2):280-4.
[6] Wang L, Sweet D H.Competitive inhibition of human organic anion transporters 1(SLC22A6), 3(SLC22A8)and 4(SLC22A11)by major components of the medicinal herb Salvia miltiorrhiza(Danshen)[J].Drug Metab Pharmacokinet, 2013,28(3):220-8.
[7] 陈 雅,李 静,张文政,等.pEGFP-NTCP 稳定转染HEK293 细胞系的建立及鉴定[J].中国药理学通报, 2016,32(12):1767-72.
[7] Chen Y, Li J, Zhang W Z, et al.Establishment and identification of HEK293 cell lines with stable and high expression of NTCP[J].Chin Pharmacol Bull, 2016,32(12):1767-72.

相似文献/References:

[1]章慧,等.重组组蛋白去乙酰化酶2-pEGFP-C2质粒的构建及表达[J].中国药理学通报,2014,(06):812.
 ZHANG Hui,HUANG Cheng,et al.Construction and expression of a pEGFP-C2-HDAC2 recombinant plamid[J].Chinese Pharmacological Bulletin,2014,(10):812.
[2]石 禹,吉宏张,包小峰.N末端Strep蛋白标签表达载体的构建和应用[J].中国药理学通报,2016,(01):98.[doi:10.3969/j.issn.1001-1978.2016.01.021]
 SHI Yu,JI Hong-zhang,et al.Construction and application of N-terminal Strep-tagged protein expression vector[J].Chinese Pharmacological Bulletin,2016,(10):98.[doi:10.3969/j.issn.1001-1978.2016.01.021]
[3]黎思彤,郑雪萍,杨学敏,等.以GLP-1受体为靶点的药物筛选模型的建立及功能鉴定[J].中国药理学通报,2017,(02):285.[doi:10.3969/j.issn.1001-1978.2017.02.026]
 LI Si-tong,ZHENG Xue-ping,YANG Xue-min,et al.Development and evaluation of a cell model targeted on GLP-1 receptor[J].Chinese Pharmacological Bulletin,2017,(10):285.[doi:10.3969/j.issn.1001-1978.2017.02.026]

备注/Memo

备注/Memo:
收稿日期:2018-06-14,修回日期:2018-07-16
基金项目:国家自然科学基金资助项目(No 81460523); 贵州省高等学校创新团队靶向药物研究与开发创新团队(黔教合人才团队字[2015]57号); 贵阳市科技计划项目(筑科合同[2018]1-36号)
作者简介:李 静(1993-),女,硕士生,研究方向:药物化学及药理学,E-mail: 2550236075@qq.com;
傅晓钟(1972-),男,博士,教授,硕士生导师,研究方向:药物化学,通讯作者,E-mail: xiaozhong_fu@sina.com;
刘 亭(1981-),男,博士,副教授,硕士生导师,研究方向:中药药理学,通讯作者,E-mail:t-liu@163.com
更新日期/Last Update: 2018-08-26